352 related articles for article (PubMed ID: 24891400)
21. Determination of Sphingosine-1-Phosphate in Human Plasma Using Liquid Chromatography Coupled with Q-Tof Mass Spectrometry.
Egom EE; Fitzgerald R; Canning R; Pharithi RB; Murphy C; Maher V
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28820460
[TBL] [Abstract][Full Text] [Related]
22. Dysfunctional High-Density Lipoproteins Are Associated With a Greater Incidence of Acute Coronary Syndrome in a Population at High Cardiovascular Risk: A Nested Case-Control Study.
Soria-Florido MT; Castañer O; Lassale C; Estruch R; Salas-Salvadó J; Martínez-González MÁ; Corella D; Ros E; Arós F; Elosua R; Lapetra J; Fiol M; Alonso-Gómez A; Gómez-Gracia E; Serra-Majem L; Pintó X; Bulló M; Ruiz-Canela M; Sorlí JV; Hernáez Á; Fitó M
Circulation; 2020 Feb; 141(6):444-453. PubMed ID: 31941372
[TBL] [Abstract][Full Text] [Related]
23. Targeting high-density lipoproteins: update on a promising therapy.
Verdier C; Martinez LO; Ferrières J; Elbaz M; Genoux A; Perret B
Arch Cardiovasc Dis; 2013 Nov; 106(11):601-11. PubMed ID: 24074699
[TBL] [Abstract][Full Text] [Related]
24. Endurance training selectively increases high-density lipoprotein-bound sphingosine-1-phosphate in the plasma.
Książek M; Charmas M; Klusiewicz A; Zabielski P; Długołęcka B; Chabowski A; Baranowski M
Scand J Med Sci Sports; 2018 Jan; 28(1):57-64. PubMed ID: 28493600
[TBL] [Abstract][Full Text] [Related]
25. KRP-203, sphingosine 1-phosphate receptor type 1 agonist, ameliorates atherosclerosis in LDL-R-/- mice.
Potì F; Gualtieri F; Sacchi S; Weißen-Plenz G; Varga G; Brodde M; Weber C; Simoni M; Nofer JR
Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1505-12. PubMed ID: 23640484
[TBL] [Abstract][Full Text] [Related]
26. High-density lipoprotein of patients with type 2 diabetes mellitus upregulates cyclooxgenase-2 expression and prostacyclin I-2 release in endothelial cells: relationship with HDL-associated sphingosine-1-phosphate.
Tong X; Peng H; Liu D; Ji L; Niu C; Ren J; Pan B; Hu J; Zheng L; Huang Y
Cardiovasc Diabetol; 2013 Jan; 12():27. PubMed ID: 23360427
[TBL] [Abstract][Full Text] [Related]
27. A Shift in ApoM/S1P Between HDL-Particles in Women With Type 1 Diabetes Mellitus Is Associated With Impaired Anti-Inflammatory Effects of the ApoM/S1P Complex.
Frej C; Mendez AJ; Ruiz M; Castillo M; Hughes TA; Dahlbäck B; Goldberg RB
Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1194-1205. PubMed ID: 28385702
[TBL] [Abstract][Full Text] [Related]
28. Sphingosine 1-Phosphate and Atherosclerosis.
Kurano M; Yatomi Y
J Atheroscler Thromb; 2018 Jan; 25(1):16-26. PubMed ID: 28724841
[TBL] [Abstract][Full Text] [Related]
29. High-density lipoprotein stimulates endothelial cell migration and survival through sphingosine 1-phosphate and its receptors.
Kimura T; Sato K; Malchinkhuu E; Tomura H; Tamama K; Kuwabara A; Murakami M; Okajima F
Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1283-8. PubMed ID: 12775579
[TBL] [Abstract][Full Text] [Related]
30. Dihydro-sphingosine 1-phosphate interacts with carrier proteins in a manner distinct from that of sphingosine 1-phosphate.
Mishima Y; Kurano M; Kobayashi T; Nishikawa M; Ohkawa R; Tozuka M; Yatomi Y
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30279204
[TBL] [Abstract][Full Text] [Related]
31. Sphingosine-1-phosphate: metabolism, transport, atheroprotection and effect of statin treatment.
Therond P; Chapman MJ
Curr Opin Lipidol; 2022 Jun; 33(3):199-207. PubMed ID: 35695616
[TBL] [Abstract][Full Text] [Related]
32. HDL quality or cholesterol cargo: what really matters--spotlight on sphingosine-1-phosphate-rich HDL.
Egom EE; Mamas MA; Soran H
Curr Opin Lipidol; 2013 Aug; 24(4):351-6. PubMed ID: 23652570
[TBL] [Abstract][Full Text] [Related]
33. Plasma lipoproteins behave as carriers of extracellular sphingosine 1-phosphate: is this an atherogenic mediator or an anti-atherogenic mediator?
Okajima F
Biochim Biophys Acta; 2002 May; 1582(1-3):132-7. PubMed ID: 12069820
[TBL] [Abstract][Full Text] [Related]
34. Cardiovascular effects of sphingosine-1-phosphate (S1P).
Levkau B
Handb Exp Pharmacol; 2013; (216):147-70. PubMed ID: 23563656
[TBL] [Abstract][Full Text] [Related]
35. Native and reconstituted HDL activate Stat3 in ventricular cardiomyocytes via ERK1/2: role of sphingosine-1-phosphate.
Frias MA; James RW; Gerber-Wicht C; Lang U
Cardiovasc Res; 2009 May; 82(2):313-23. PubMed ID: 19151362
[TBL] [Abstract][Full Text] [Related]
36. Diabetes Mellitus Is Associated With Reduced High-Density Lipoprotein Sphingosine-1-Phosphate Content and Impaired High-Density Lipoprotein Cardiac Cell Protection.
Brinck JW; Thomas A; Lauer E; Jornayvaz FR; Brulhart-Meynet MC; Prost JC; Pataky Z; Löfgren P; Hoffstedt J; Eriksson M; Pramfalk C; Morel S; Kwak BR; van Eck M; James RW; Frias MA
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):817-24. PubMed ID: 26966278
[TBL] [Abstract][Full Text] [Related]
37. Liver involvement in sphingosine 1-phosphate dynamism revealed by adenoviral hepatic overexpression of apolipoprotein M.
Kurano M; Tsukamoto K; Ohkawa R; Hara M; Iino J; Kageyama Y; Ikeda H; Yatomi Y
Atherosclerosis; 2013 Jul; 229(1):102-9. PubMed ID: 23664237
[TBL] [Abstract][Full Text] [Related]
38. Enhanced release of sphingosine-1-phosphate from hypercholesterolemic platelets: role in development of hypercholesterolemic atherosclerosis.
Son DJ; Lee HW; Shin HW; Lee JJ; Yoo HS; Kim TJ; Yun YP; Hong JT
Prostaglandins Leukot Essent Fatty Acids; 2008 Jun; 78(6):383-90. PubMed ID: 18571912
[TBL] [Abstract][Full Text] [Related]
39. Epidemiology: disease associations and modulators of HDL-related biomarkers.
Savolainen MJ
Handb Exp Pharmacol; 2015; 224():259-83. PubMed ID: 25522991
[TBL] [Abstract][Full Text] [Related]
40. The compensatory enrichment of sphingosine -1- phosphate harbored on glycated high-density lipoprotein restores endothelial protective function in type 2 diabetes mellitus.
Tong X; Lv P; Mathew AV; Liu D; Niu C; Wang Y; Ji L; Li J; Fu Z; Pan B; Pennathur S; Zheng L; Huang Y
Cardiovasc Diabetol; 2014 Apr; 13():82. PubMed ID: 24751283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
